Table 7.

Drug treatment after 21 months of observations, during COVID-19.

Drugs at Recruitment	Medium Dose (mg/day)	Male Dose (mg/day)	Female Dose (mg/day)
Rac-methadone	66.25 ± 30.82	71.15 ± 31.27	57.14 ± 27.76
Levomethadone	58.33 ± 31.58	58.33 ± 31.58	No patients
Buprenorphine\naloxone	8.27 ± 4.94	8.88 ± 5.18	6.67 ± 3.77
Drugs after 21 Months	Male Dose (mg/day)	Female Dose (mg/day)	Medium Dose (mg/day)
Rac-methadone	59.00 ± 31.42	55.50 ± 34.89	66.00 ± 21.31
Levomethadone	62.22 ± 24.28	62.22 ± 24.28	No patients
Buprenorphine\naloxone	7.00 ± 3.79	7.13 ± 3.79	6.61 ± 2.17